News

New Research Grant Award

Dr. Cairo was recently awarded a 4-year grant from the Department of Defense. Novel combinatorial targeted chimeric antigen receptor natural killer cell based cellular immunotherapy with adjuvant immunomodulation in patients with AML The objecitve of this grant funded research is to enhance mission readiness by reducing the gaps in AML prognosis (dismal outcomes) and create

New Research Grant Award Read More »